Cargando…
Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection
Chemotherapy and targeted therapies have significantly improved the prognosis of oncology patients. However, these antineoplastic treatments may also induce adverse cardiovascular effects, which may lead to acute or delayed onset of cardiac dysfunction. These common cardiovascular complications, com...
Autores principales: | Morelli, Marco Bruno, Bongiovanni, Chiara, Da Pra, Silvia, Miano, Carmen, Sacchi, Francesca, Lauriola, Mattia, D’Uva, Gabriele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051244/ https://www.ncbi.nlm.nih.gov/pubmed/35497981 http://dx.doi.org/10.3389/fcvm.2022.847012 |
Ejemplares similares
-
Reawakening the Intrinsic Cardiac Regenerative Potential: Molecular Strategies to Boost Dedifferentiation and Proliferation of Endogenous Cardiomyocytes
por: Bongiovanni, Chiara, et al.
Publicado: (2021) -
Neuregulin 4 Boosts the Efficacy of Anti-ERBB2 Neutralizing Antibodies
por: Miano, Carmen, et al.
Publicado: (2022) -
NRG1/ERBB3/ERBB2 Axis Triggers Anchorage-Independent Growth of Basal-like/Triple-Negative Breast Cancer Cells
por: Miano, Carmen, et al.
Publicado: (2022) -
Cardiotoxicity of Anticancer Therapeutics
por: Dong, Jerry, et al.
Publicado: (2018) -
Selective protein kinase C inhibition switches time-dependent glucose cardiotoxicity to cardioprotection
por: Brennan, Sean, et al.
Publicado: (2022)